Trehalose: Current Use and Future Applications

被引:390
作者
Ohtake, Satoshi [1 ]
Wang, Y. John [2 ]
机构
[1] Aridis Pharmaceut, San Jose, CA 95138 USA
[2] Genentech Inc, Late Stage Pharmaceut & Proc Dev Dept, San Francisco, CA 94080 USA
关键词
trehalose; stability; formulation; excipients; glass; physicochemical; food; cosmetic; ET-KYOTO SOLUTION; STRESS-SPECIFIC STABILIZATION; PHASE-TRANSITION TEMPERATURE; DRYING-INDUCED DENATURATION; FREEZE-DRIED LIPOSOMES; PROTEIN STABILITY; CANINE LUNG; LYOPHILIZED FORMULATIONS; SACCHAROMYCES-CEREVISIAE; GLASS-TRANSITION;
D O I
10.1002/jps.22458
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Trehalose, a disaccharide of glucose, has been reported to accumulate in many organisms that can withstand extended periods of inanimation. Since this discovery, the properties of trehalose have been examined extensively to understand its role and abundance in nature. The unique features of this sugar became clearer with each new finding which demonstrated its ability to sustain and preserve a wide array of biological molecules. Trehalose has been used in a variety of research applications and is contained in several commercially available therapeutic products, including Herceptin (R), Avastin (R), Lucentis (R), and Advate (R). Currently, there is a growing interest in the use of trehalose in solid dosage formulations, most notably in quick-dissolving tablets. Furthermore, trehalose has found its use in several food and cosmetic products, and new applications capitalizing on its unique properties are being developed and implemented in everyday-use products. As trehalose is an approved ingredient in all major markets, there is no significant barrier to its use. Extensive work with trehalose has been conducted in the three major industries, however with little overlap. Further understanding of the role of trehalose in the various applications may lead to an increase in the number of trehalose-containing products. (C) 2011 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 100:2020-2053, 2011
引用
收藏
页码:2020 / 2053
页数:34
相关论文
共 307 条
[11]   STABILIZATION OF PROTEIN-STRUCTURE BY SUGARS [J].
ARAKAWA, T ;
TIMASHEFF, SN .
BIOCHEMISTRY, 1982, 21 (25) :6536-6544
[12]   Factors affecting short-term and long-term stabilities of proteins (Reprinted from Advanced Drug Delivery Reviews, vol 9, pg 201-237, 1992) [J].
Arakawa, T ;
Prestrelski, SJ ;
Kenney, WC ;
Carpenter, JF .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :307-326
[13]   PROTEIN-SOLVENT INTERACTIONS IN PHARMACEUTICAL FORMULATIONS [J].
ARAKAWA, T ;
KITA, Y ;
CARPENTER, JF .
PHARMACEUTICAL RESEARCH, 1991, 8 (03) :285-291
[14]   Physiological roles of trehalose in bacteria and yeasts:: a comparative analysis [J].
Argüelles, JC .
ARCHIVES OF MICROBIOLOGY, 2000, 174 (04) :217-224
[15]   LARGE AMOUNT OF TREHALOSE IN FROST-RESISTANT INSECT [J].
ASAHINA, E ;
TANNO, K .
NATURE, 1964, 204 (496) :1222-+
[17]   High-throughput screening of stabilizers for respiratory syncytial virus - Identification of stabilizers and their effects on the conformational thermostability of viral particles [J].
Ausar, Salvador F. ;
Espina, Marianela ;
Brock, Julie ;
Thyagarayapuran, Nagaraian ;
Repetto, Robert ;
Khandke, Lakshmi ;
Middaugh, C. Russell .
HUMAN VACCINES, 2007, 3 (03) :94-103
[18]   Comparison of Euro-Collins solution, low-potassium dextran solution containing glucose, and ET-Kyoto solution for lung preservation in an extracorporeal rat lung perfusion model [J].
Bando, T ;
Albes, JM ;
Nüsse, T ;
Wada, H ;
Hitomi, S ;
Schäfers, HJ .
EUROPEAN SURGICAL RESEARCH, 1998, 30 (05) :297-304
[19]  
BANDO T, 1994, J THORAC CARDIOV SUR, V108, P92
[20]   Thermodynamics and mechanism of cutinase stabilization by trehalose [J].
Baptista, Ricardo P. ;
Pedersen, Shona ;
Cabrita, Gon Alo J. M. ;
Otzen, Daniel E. ;
Cabral, Joaquirn M. S. ;
Melo, Eduardo P. .
BIOPOLYMERS, 2008, 89 (06) :538-547